ZOM
Income statement / Annual
Last year (2025), Zomedica Corp.'s total revenue was $27.29 M,
an increase of 8.33% from the previous year.
In 2025, Zomedica Corp.'s net income was -$46.98 M.
See Zomedica Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$27.29 M |
$25.19 M |
$18.93 M |
$4.13 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$8.20 M
|
$7.87 M
|
$5.28 M
|
$1.08 M
|
$530.02 K
|
$787.61 K
|
$205.77 K
|
$92.41 K
|
$45.82 K
|
$0.00
|
| Gross Profit |
$19.09 M
|
$17.32 M
|
$13.65 M
|
$3.05 M
|
-$530.02 K
|
-$787.61 K
|
-$205.77 K
|
-$92.41 K
|
-$45.82 K
|
$0.00
|
| Gross Profit Ratio |
0.7
|
0.69
|
0.72
|
0.74
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$7.27 M
|
$5.74 M
|
$2.58 M
|
$1.67 M
|
$8.04 M
|
$10.35 M
|
$10.32 M
|
$2.75 M
|
$1.52 M
|
$758.05 K
|
| General & Administrative Expenses |
$29.66 M
|
$29.03 M
|
$22.93 M
|
$0.00
|
$7.93 M
|
$8.18 M
|
$5.83 M
|
$5.08 M
|
$4.24 M
|
$1.43 M
|
| Selling & Marketing Expenses |
$17.19 M
|
$14.14 M
|
$9.88 M
|
$0.00
|
$261.91 K
|
$471.89 K
|
$225.89 K
|
$164.25 K
|
$194.19 K
|
$143.47 K
|
| Selling, General & Administrative Expenses |
$46.85 M
|
$43.17 M
|
$33.00 M
|
$22.75 M
|
$8.19 M
|
$8.65 M
|
$6.06 M
|
$5.24 M
|
$4.43 M
|
$1.57 M
|
| Other Expenses |
$16.02 M
|
$0.00
|
-$7.00 K
|
$6.00 K
|
$530.02 K
|
$787.61 K
|
$205.77 K
|
$92.41 K
|
$45.82 K
|
$0.00
|
| Operating Expenses |
$70.14 M
|
$48.91 M
|
$35.58 M
|
$24.43 M
|
$16.76 M
|
$19.78 M
|
$16.58 M
|
$8.08 M
|
$6.00 M
|
$2.28 M
|
| Cost And Expenses |
$78.34 M
|
$56.78 M
|
$40.85 M
|
$25.51 M
|
$16.76 M
|
$19.78 M
|
$16.58 M
|
$8.08 M
|
$6.00 M
|
$2.28 M
|
| Interest Income |
$3.97 M
|
$5.46 M
|
$2.70 M
|
$357.45 K
|
$32.86 K
|
$18.34 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$175.00 K
|
$1.00 K
|
$6.05 K
|
$732.00
|
$18.34 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$7.99 M
|
$6.30 M
|
$4.04 M
|
$1.14 M
|
$530.02 K
|
$787.61 K
|
$205.77 K
|
$92.41 K
|
$45.82 K
|
$9.05 K
|
| EBITDA |
-$39.55 M |
-$29.39 M |
-$15.34 M |
-$19.57 M |
-$16.38 M |
-$19.00 M |
-$16.44 M |
-$7.97 M |
-$5.97 M |
-$2.28 M |
| EBITDA Ratio |
-1.45
|
-1.17
|
-0.81
|
-4.74
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-1.87
|
-1.25
|
-1.16
|
-5.17
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.51 M
|
-$4.27 M
|
$2.54 M
|
$657.78 K
|
-$146.81 K
|
$273.00
|
-$68.44 K
|
$18.98 K
|
$258.06 K
|
$7.44 K
|
| Income Before Tax |
-$47.54 M
|
-$35.86 M
|
-$19.38 M
|
-$20.72 M
|
-$16.91 M
|
-$19.78 M
|
-$16.65 M
|
-$8.07 M
|
-$6.01 M
|
-$2.28 M
|
| Income Before Tax Ratio |
-1.74
|
-1.42
|
-1.02
|
-5.01
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$557.00 K
|
-$1.33 M
|
-$2.37 M
|
-$2.33 M
|
$9.33 K
|
$38.08 K
|
$136.88 K
|
-$18.98 K
|
$28.59 K
|
$0.00
|
| Net Income |
-$46.98 M
|
-$34.53 M
|
-$17.02 M
|
-$18.38 M
|
-$16.92 M
|
-$19.82 M
|
-$16.65 M
|
-$8.07 M
|
-$6.01 M
|
-$2.28 M
|
| Net Income Ratio |
-1.72
|
-1.37
|
-0.9
|
-4.45
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.048 |
-0.0352 |
-0.0174 |
-0.0192 |
-0.0464 |
-0.19 |
-0.18 |
-0.0923 |
-0.075 |
-0.0493 |
| EPS Diluted |
-0.048 |
-0.0352 |
-0.0174 |
-0.0192 |
-0.0464 |
-0.19 |
-0.18 |
-0.0923 |
-0.075 |
-0.0493 |
| Weighted Average Shares Out |
$979.95 M
|
$979.95 M
|
$979.92 M
|
$956.53 M
|
$364.44 M
|
$106.30 M
|
$92.49 M
|
$87.40 M
|
$80.16 M
|
$46.23 M
|
| Weighted Average Shares Out Diluted |
$979.95 M
|
$979.95 M
|
$979.92 M
|
$956.53 M
|
$364.44 M
|
$106.30 M
|
$93.44 M
|
$87.40 M
|
$80.16 M
|
$46.23 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
